CAS 144689-24-7
:Olmesartan
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
- 1H-Imidazole-5-carboxylicacid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
- Cs 088
- Olmesartan
- Olmetor
- Rnh 6270
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Olmesartan
CAS:Formel:C24H26N6O3Reinheit:>98.0%(HPLC)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:446.511-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-4-(2-Hydroxypropan-2-Yl)-2-Propyl-1H-Imidazole-5-Carboxylic Acid
CAS:1-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-4-(2-Hydroxypropan-2-Yl)-2-Propyl-1H-Imidazole-5-Carboxylic AcidFormel:C24H26N6O3Reinheit:98%Molekulargewicht:446.5Olmesartan (Olmesartan Medoxomil EP Impurity A)
CAS:Formel:C24H26N6O3Farbe und Form:White To Off-White SolidMolekulargewicht:446.51Olmesartan
CAS:Formel:C29H30N6O6Reinheit:(HPLC) ≥ 98.0%Farbe und Form:White to off-white powderMolekulargewicht:558.594-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (Olmesartan)
CAS:Kontrolliertes ProduktFormel:C24H26N6O3Farbe und Form:NeatMolekulargewicht:446.54-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
CAS:Formel:C24H26N6O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:446.5016Olmesartan (Standard)
CAS:Olmesartan (Standard) is a reference standard for research and analysis in studies involving Olmesartan. Olmesartan (RNH 6270) is an Angiotensin II Type I receptor antagonist. Olmesartan is the active form of the antihypertensive drug olmesartan medoxomil,and has antihypertensive activity.Formel:C24H26N6O3Molekulargewicht:446.5016Olmesartan 100 µg/mL in Acetonitrile:Methanol
CAS:Kontrolliertes ProduktFormel:C24H26N6O3Farbe und Form:Single SolutionMolekulargewicht:446.5Olmesartan Acid
CAS:Kontrolliertes ProduktImpurity Olmesartan EP Impurity A
Applications Olmesartan Acid (Olmesartan EP Impurity A) is an angiotensin II receptor antagonist. Used as an anti-hypertensive.
References Yanagisawa, H., et al.: J. Med. Chem., 39, 323 (1996), Puchler, K., et al.: J. Hypertens., 15, 1809 (1997),Formel:C24H26N6O3Farbe und Form:NeatMolekulargewicht:446.5Olmesartan
CAS:Olmesartan (RNH 6270) is an Angiotensin II Type I receptor antagonist.Formel:C24H26N6O3Reinheit:91.89% - 99.81%Farbe und Form:White SolidMolekulargewicht:446.5016Olmesartan
CAS:1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acidFormel:C24H26N6O3Reinheit:98%Molekulargewicht:446.5Olmesartan
CAS:Olmesartan medoxomil is a prodrug that is hydrolyzed to olmesartan, its active form. It is a member of the angiotensin II receptor antagonists and it is used for the treatment of hypertension and heart failure. Olmesartan medoxomil reduces the risk of cardiovascular events in patients with resistant hypertension or heart failure. The drug binds to the angiotensin II type 1 receptor, thereby blocking the binding of angiotensin II to this receptor. This prevents activation of downstream signaling pathways, including phospholipase C, protein kinase C, and mitogen-activated protein kinases. Olmesartan medoxomil also blocks the formation of new blood vessels and vascular remodeling in animal models.
Formel:C24H26N6O3Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:446.5 g/mol















